Avaleht › Põievähk › Ohio › Cleveland
Põievähk kliinilised uuringud linnas Cleveland, OH
18 uuringut haiguse Põievähk jaoks otsivad osalejaid linnas Cleveland ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
VärbamineFaas 1
- University Hospitals Cleveland Medical Center, Cleveland
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
VärbamineFaas 1/2
- Cleveland Clinic Taussig Cancer ( Site 5036), Cleveland
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
VärbamineFaas 2
- Cleveland Clinic - Oncology Department, Cleveland
Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
VärbamineFaas 2
- Cleveland Clinic Taussig Cancer Center, Cleveland
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
VärbamineFaas 2
- MetroHealth Medical Center, Cleveland
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
VärbamineFaas 1/2
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Foundation, Cleveland
- Cleveland Clinic Taussig Cancer Center Investigational Pharmacy, Cleveland
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
VärbamineFaas 1
- University Hospitals Cleveland Medical Center, Cleveland
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
VärbamineVaatlusuuring
- Cleveland Clinic, Cleveland
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
VärbamineFaas 2
- Cleveland Clinic, Cleveland
The Vanguard Study: Testing a New Way to Screen for Cancer
VärbamineTerved vabatahtlikud oodatud
- Louis Stokes Cleveland VA Medical Center, Cleveland
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
VärbamineFaas 2
- Cleveland Clinic Main Campus, Cleveland, Cleveland
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
VärbamineFaas 3
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi kaugusel
- UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi kaugusel
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
VärbamineFaas 2/3
- Fairview Hospital, Cleveland
- Cleveland Clinic, Cleveland
- Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 mi kaugusel
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
VärbamineFaas 3
- Research Site, Cleveland
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
VärbamineFaas 2
- University Hospitals Cleveland Medical Center, Cleveland
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
VärbamineFaas 1/2
- Cleveland Clinic, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
VärbamineVaatlusuuring
- Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi kaugusel
Põievähk uuringud teistes linnades
- New York City, NY35 uuringut
- Nashville, TN31 uuringut
- Houston, TX31 uuringut
- Dallas, TX27 uuringut
- Boston, MA26 uuringut
- Washington, DC26 uuringut
- Los Angeles, CA24 uuringut
- Baltimore, MD24 uuringut
- St. Louis, MO22 uuringut
- Philadelphia, PA21 uuringut
- Seattle, WA21 uuringut
- Edison, NJ21 uuringut
Muud uuringud linnas Cleveland
- Mitteväikerakuline kopsuvähk43 uuringut
- Vähk (kõik liigid)36 uuringut
- Rinnavähk35 uuringut
- Eesnäärmevähk34 uuringut
- Südamepuudulikkus33 uuringut
- Metastaatiline vähk30 uuringut
- Munasarjavähk30 uuringut
- Kopsuvähk26 uuringut
- Käär- ja pärasoolevähk24 uuringut
- Kardiovaskulaarsed haigused22 uuringut
- Endomeetriumivähk20 uuringut
- Äge müeloidne leukeemia20 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.